1. Home
  2. Labeler Index
  3. Haleon Us Holdings Llc
  4. NDC Product Code: 0135-0400 Abreva Rapid Pain Relief

NDC 0135-0400 Abreva Rapid Pain Relief

Glycerin,Lidocaine Gel Topical - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 0135-0400?
  4. Abreva Rapid Pain Relief Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk
  9. Pharmacologic Classes

Product Information

NDC Product Code:
0135-0400
Proprietary Name:
Abreva Rapid Pain Relief
Non-Proprietary Name: [1]
Glycerin, Lidocaine
Substance Name: [2]
Glycerin; Lidocaine Hydrochloride
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route(s): [4]
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
    • Labeler Name: [5]
    Haleon Us Holdings Llc
    Labeler Code:
    0135
    Product Label ID:
    65bd242f-4c6a-436c-8ec0-7b2e0d73ed9d
    FDA Application Number: [6]
    M017
    Marketing Category: [8]
    OTC MONOGRAPH DRUG -
    Start Marketing Date: [9]
    06-01-2023
    Listing Expiration Date: [11]
    12-31-2025
    Exclude Flag: [12]
    N
    Code Navigator:

    Code Structure Chart

    Product Details

    What is NDC 0135-0400?

    The NDC code 0135-0400 is assigned by the FDA to the product Abreva Rapid Pain Relief which is a human over the counter drug product labeled by Haleon Us Holdings Llc. The generic name of Abreva Rapid Pain Relief is glycerin, lidocaine. The product's dosage form is gel and is administered via topical form. The product is distributed in a single package with assigned NDC code 0135-0400-01 1 tube in 1 package / 3 g in 1 tube. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Abreva Rapid Pain Relief?

    •push and turn cap to open, close tightly after use•wash hands before and after applying•adults and children 12 years of age and older: apply to affected area not more than 3 to 4 times daily•children under 12 years: consult a doctor

    What are Abreva Rapid Pain Relief Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
    • GLYCERIN 200 mg/g
    • LIDOCAINE HYDROCHLORIDE 40 mg/g - A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.

    Which are Abreva Rapid Pain Relief UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Abreva Rapid Pain Relief Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Abreva Rapid Pain Relief?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
    • RxCUI: 2637870 - glycerin 20 % / lidocaine hydrochloride 4 % Topical Gel
    • RxCUI: 2637870 - glycerin 0.2 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel
    • RxCUI: 2637875 - Abreva Rapid Pain Relief 20 % / 4 % Topical Gel
    • RxCUI: 2637875 - glycerin 0.2 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel [Abreva Rapid Pain Relief]
    • RxCUI: 2637875 - Abreva Rapid Pain Relief (glycerin 20 % / lidocaine hydrochloride 4 % ) Topical Gel

    Which are the Pharmacologic Classes for Abreva Rapid Pain Relief?

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".